Patents by Inventor Richard Colin Green

Richard Colin Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations comprising antisense nucleotides to connexins
    Patent number: 7919474
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: April 5, 2011
    Assignee: CoDa Therapeutics, Inc.
    Inventors: Richard Colin Green, David Laurence Becker
  • Formulations comprising antisense nucleotides to connexins
    Patent number: 7902164
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Grant
    Filed: August 29, 2006
    Date of Patent: March 8, 2011
    Assignee: Coda Therapeutics, Inc.
    Inventors: Richard Colin Green, David Laurence Becker
  • Formulations comprising antisense nucleotides to connexins
    Patent number: 7879811
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: February 1, 2011
    Assignee: Coda Therapeutics, Inc.
    Inventors: Richard Colin Green, David Laurence Becker
  • Formulations comprising antisense nucleotides to connexins
    Patent number: 7615540
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: November 10, 2009
    Assignee: CoDaTherapeutics, Ltd.
    Inventors: Richard Colin Green, David Laurence Becker